Program

November 14th, 2025

7:00 am Registration / Inaugural

Session I - AML Diagnostics / Prognostication

Chair Person : Dr. Biju George
8:00 am AML Diagnostics: View from Australia
Dr. Anoop Enjeti
Calvary Mater Hospital, Newcastle
8:30 am How do we improve the current classification of Acute Myeloid Leukemia?
Dr. Nikhil Patkar
Tata Memorial Centre, Mumbai
9:00 am A diagnostic service laboratory experience of running NGS Myeloid service
Dr. Neeraj Arora
Unipath Specialty Laboratory Limited, Ahmedabad
9:30 am Panel Discussion

Moderator: Dr. Anoop Enjeti

Panelists:
Dr. Nikhil Patkar
Tata Memorial Centre, Mumbai
Dr. Neeraj Arora
Unipath Specialty Laboratory Limited, Ahmedabad
Dr. Alpeshkumar Bipinbhai Kapadia
Christian Medical College Vellore
Dr. Phaneendra Datari
Christian Medical College Vellore
Dr. Poonkuzhali Balasubramanian
Christian Medical College Vellore
Dr. Sachin Jain
10:00 am - 10:30 am Morning Break

Session II - AML Treatment - (Non-transplant)

Chair Person : Dr. Sharon Anbumalar Lionel
10:30 am Targeted therapies in AML: FLT3, IDH, TP53 and beyond
Dr. Jayastu Senapati
MD Anderson Cancer Center, Houston
11:15 am Venetoclax-based combinations in AML : Global and Indian perspectives
Dr. Uday Kulkarni
Christian Medical College Vellore
11:45 am Disease Models in Myeloid Malignancies – iPSCs and Beyond
Dr. Ramachandran Shaji
Christian Medical College Vellore
12:15 pm Panel Discussion
  • Integrating Targeted Therapy and Venetoclax in Indian AML Practice
  • AML 2025: Is Cure Possible Without Transplant?
  • MRD and New Agents – Moving Towards Personalized AML Care in India 

Moderator: Dr Sharon Anbumalar Lionel 

Panelists:
Dr. Jayastu Senapati
MD Anderson Cancer Center, Houston
Dr. Kasi Viswanathan
Meenakshi Mission Hospital And Research Centre, Madurai
Dr. Neeraj Siddharthan
Amrita Hospital, Kochi
Dr. Subbaiah Ramanathan
Dr. Uday Kulkarni
Christian Medical College Vellore
Dr. Vikram Mathews
Christian Medical College Vellore
12:45 pm - 1:15 pm Lunch
1:15 pm Sponsored Session: Abbvie Healthcare India Pvt Ltd – Evolving treatments in IC ineligible AML Bridging clinical trial evidence and real-world practice
Dr. Ofir Wolach
Israel

Session III - AML Treatment Transplant

Chair Person : Dr. Anu Korula
1:45 pm Optimising allogeneic transplant in AML : Who, When, and How? (Virtual)
Dr. Ashish Bajel
The Royal Melbourne Hospital, Australia
2:30 pm Strategies to improve post-transplant outcomes in AML
Dr. Navin Khattry
Tata Memorial Centre, Mumbai
3:00 pm Panel Discussion

Focus on conditioning, GVHD Prophylaxis
management of relapse post transplant

Moderator: Dr Sharat Damodar 

Panelists:
Dr. Neeraj Siddharthan
Amrita Hospital, Kochi
Dr. Chepsy Philip
Christian Medical College Vellore
Dr. Uday Kulkarni
Christian Medical College Vellore
Dr. Sujith K
Christian Medical College Vellore
Dr. Punit Jain
Apollo Hospitals, Mumbai
Dr. Abhijit Baheti

Session IV - MPN: Recent Advances

Chair Person : Dr. Chepsy C Philip
3:30 pm Primary Myelofibrosis: Current approach and contemporary therapies
Dr. M Joseph John
Christian Medical College, Ludhiana
4:00 pm Polycythemia Vera in 2025
Dr. Neeraj Siddharthan
Amrita Hospital, Kochi
4:30 pm - 4:45 pm Coffee break
4:45 pm Sponsored Session : Astellas Pharma India Pvt. Ltd (Virtual) – Outcomes and recent advances with Xospata in R/R FLT3 mutated AML
Dr. Jessica Altman
Chicago

Session V - CML And Acute Leukemias Of Ambiguous Lineage

Chair Person : Dr. Joseph M John
5:15 pm Diagnostic dilemmas in MPAL, and other Ambigous Leukemia
Dr. Phaneendra Datari
Christian Medical College Vellore
5:45 pm Therapeutic strategies in MPAL: All-like vs AML-like vs Hybrid protocols
Dr. Punit Jain
Apollo Hospitals, Mumbai
6:15 pm CML in special populations: Pediatric, Geriatric, and Pregnancy-associated cases
Dr. Sanjeevan Sharma
Army Hospital New Delhi
6:45 pm Transplantation in CML: Still relevant in the era of TKIS?
Dr. Kasi Viswanathan
Meenakshi Mission Hospital And Research Centre, Madurai
7:15 pm - 8:30 pm Closing Ceremony & Dinner